C-MER Medical Releases 2025 Annual Report and Adopts Full Electronic Dissemination of Corporate Communications

Bulletin Express
04/17

On 20 April 2026, C-MER Medical Holdings Limited announced that its 2025 Annual Report and accompanying Circular are now available in both English and Chinese on the Hong Kong Stock Exchange website (www.hkexnews.hk) and the company’s website (www.cmermedical.com).

Key points from the notification are as follows:

1. Compliance with Paperless Listing Regime • In line with Listing Rule 2.07A, C-MER Medical has adopted electronic dissemination for all future corporate communications, including annual and interim reports, meeting notices, circulars and proxy forms. • Printed copies will be supplied only upon shareholder request and at no cost.

2. Arrangement for Non-Registered Shareholders • Holders whose shares are kept through CCASS must provide a functional email address to their designated bank, broker, custodian or other intermediary to receive electronic notifications. • Until a valid email is supplied, these shareholders must monitor the company and HKEX websites for new documents and will receive only actionable communications (e.g., proxy forms) in hard copy.

3. Request Procedure for Printed Materials • Shareholders may obtain printed versions by emailing cmermedical.ecom@computershare.com.hk or writing to Computershare Hong Kong Investor Services Limited, 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong. • The registrar’s enquiry hotline is (852) 2862 8688, available weekdays from 9:00 a.m. to 6:00 p.m. (Hong Kong time).

4. Board Authorisation • The notice was issued under the authority of the Board and signed by Vice Chairman, Executive Director and Chief Executive Officer Ms. Li Xiaoting.

The company emphasised that the electronic-first approach aligns with Hong Kong’s expanded paperless regime and aims to streamline shareholder communication while reducing environmental impact.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10